1. From the Department of Medicine II and Cardiovascular Center (K.A., H.M., O.I., M.O., S.F., T. Imada, T. Iwasaka) and Radiology (H.K.), Kansai Medical University, Moriguchi, Osaka, Japan; Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co Ltd (Y.N.), Saitama, Japan; and the Division of Cardiovascular and Respiratory Medicine, Kobe University Graduate School of Medicine (S.K., M.Y.), Kobe, Japan.